Format

Send to:

Choose Destination
See comment in PubMed Commons below
Seizure. 2006 Apr;15(3):137-41. Epub 2006 Jan 19.

The use of levetiracetam in refractory status epilepticus.

Author information

  • 1Pediatric Neurology, M756, MSB, DC058.00, One Hospital Drive Columbia, MO 65212, USA. PatelN@health.missouri.edu

Abstract

Six patients with status epilepticus (SE) of various etiologies refractory to at least two antiepileptic drugs (AEDs) had complete cessation of their seizures following administration of oral levetiracetam (LEV). Seizure types included convulsive, focal, and nonconvulsive status epilepticus. Effective doses of levetiracetam ranged from 500 to 3000 mg/day, achieving seizure control within 12-96 h. No significant adverse events were noted. Adjunctive levetiracetam should be considered for patients with status epilepticus unresponsive to initial therapy.

PMID:
16426869
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk